Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126142084 | 12614208 | 4 | F | 20160630 | 20160916 | 20160802 | 20160922 | EXP | US-LUNDBECK-DKLU2016910 | LUNDBECK | 44.63 | YR | F | Y | 76.00000 | KG | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126142084 | 12614208 | 1 | PS | NORTHERA | DROXIDOPA | 1 | Unknown | TITRATION SCHEDULE B (NOW CUSTOMIZED) | U | N | 203202 | CAPSULE | |||||||
| 126142084 | 12614208 | 2 | SS | NORTHERA | DROXIDOPA | 1 | Unknown | U | N | 203202 | 400 | MG | TID | ||||||
| 126142084 | 12614208 | 3 | SS | NORTHERA | DROXIDOPA | 1 | Unknown | U | N | 203202 | 300 | MG | TID | ||||||
| 126142084 | 12614208 | 4 | SS | NORTHERA | DROXIDOPA | 1 | Unknown | U | N | 203202 | 100 | MG | TID | ||||||
| 126142084 | 12614208 | 5 | SS | NORTHERA | DROXIDOPA | 1 | Oral | U | N | 203202 | 300 | MG | TID | ||||||
| 126142084 | 12614208 | 6 | SS | NORTHERA | DROXIDOPA | 1 | Unknown | U | N | 203202 | |||||||||
| 126142084 | 12614208 | 7 | SS | TOPAMAX | TOPIRAMATE | 1 | Unknown | U | 0 | ||||||||||
| 126142084 | 12614208 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | 25 | UG | QD | ||||||||
| 126142084 | 12614208 | 9 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | 20 | MG | QD | ||||||||
| 126142084 | 12614208 | 10 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126142084 | 12614208 | 1 | Autonomic neuropathy |
| 126142084 | 12614208 | 7 | Migraine |
| 126142084 | 12614208 | 8 | Hypothyroidism |
| 126142084 | 12614208 | 9 | Factor V deficiency |
| 126142084 | 12614208 | 10 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126142084 | 12614208 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126142084 | 12614208 | Blood magnesium increased | |
| 126142084 | 12614208 | Dizziness | |
| 126142084 | 12614208 | Dyspnoea | |
| 126142084 | 12614208 | Fatigue | |
| 126142084 | 12614208 | Feeling abnormal | |
| 126142084 | 12614208 | Gout | |
| 126142084 | 12614208 | Headache | |
| 126142084 | 12614208 | Incorrect dose administered | |
| 126142084 | 12614208 | Lethargy | |
| 126142084 | 12614208 | Nausea | |
| 126142084 | 12614208 | Palpitations | |
| 126142084 | 12614208 | Somnolence | |
| 126142084 | 12614208 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126142084 | 12614208 | 1 | 20160630 | 0 | ||
| 126142084 | 12614208 | 2 | 20160706 | 20160706 | 0 | |
| 126142084 | 12614208 | 3 | 20160707 | 0 | ||
| 126142084 | 12614208 | 5 | 20160715 | 0 |